Breaking News, Promotions & Moves

Amgen CEO, R&D Head To Retire

Sharer, Perlmutter to hand reins to Bradway, Harper in 2012

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Kevin W. Sharer will retire from his roles as chairman and chief executive officer of Amgen in 2012. He held both those roles since 2000 and has been at Amgen for 20 years of service to Amgen. Mr. Sharer will step down as CEO effective May 23, 2012, and remain as chairman until December 31, 2012. Robert Bradway, currently president and chief operating officer, will replace Mr. Sharer in both roles. In addition, Roger Perlmutter will retire as executive vice president of R&D effective Februa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters